Personalized neurometabolic signature predicts seizure outcomes of laser ablation in mesial temporal lobe epilepsy
The pNMS provides an individualized imaging marker for guiding laser ablation and predicting postoperative seizure outcomes. This approach supports more precise surgical planning and may improve long-term prognosis in patients with mesial temporal lobe epilepsy.
Authors
- Baotian Zhao (ORCID: https://orcid.org/0000-0003-0920-6825)
- Jiajie Mo (ORCID: https://orcid.org/0000-0002-9721-1378)
- Xiaoqiu Shao (ORCID: https://orcid.org/0000-0001-5798-7115)
- Kai Zhang (ORCID: https://orcid.org/0000-0002-7885-3658)
- Chao Zhang (ORCID: https://orcid.org/0000-0003-2776-5647)
- Jianguo Zhang (ORCID: https://orcid.org/0000-0002-0009-0574)
- Xiu Wang (ORCID: https://orcid.org/0000-0002-4800-6706)
- Lin Sang
- Wenhan Hu
- Rong Li (ORCID: https://orcid.org/0000-0001-7266-0241)
Institutions
- University of Electronic Science and Technology of China (CN)
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Beijing Institute of Neurosurgery (CN)
- Beijing Fengtai Hospital (CN)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1038/s43856-025-01167-0
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Capital Medical University
- Beijing Association for Science and Technology